Dandelion polysaccharide composition with effect of assisting in inhibiting colon cancer and dandelion polysaccharide preparation

By preparing modified dandelion polysaccharide components DRP1 and DRP2, the problem of limited efficacy of dandelion polysaccharides in inhibiting colon cancer in existing technologies has been solved, achieving efficient and safe colon cancer inhibition and inflammation regulation, especially significantly reducing dosage requirements in the inflammation-cancer pathway.

CN118955751APending Publication Date: 2024-11-15INST OF AGRI MECHANIZATION XINJIANG AGRI INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411059550.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-04
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

In the existing technology, the effect of dandelion polysaccharide in adjuvant inhibition of colon cancer is limited, especially in the inflammation-cancer pathway, particularly in inflammatory bowel disease carcinogenesis caused by ulcerative colitis, and requires a large dose of polysaccharide intake to be effective. Moreover, existing studies have not explored the antitumor effects of different polysaccharide components after isolation and purification.

Method used

Modified polysaccharide components DRP1 and DRP2 were prepared, including the extraction, separation, purification, and selenization modification of crude dandelion polysaccharide. Small molecule inorganic compounds and oligosaccharides were removed, the bioactivity of the polysaccharide components was improved, and they were prepared into powders, tablets, pills, or liquids.

Benefits of technology

It effectively inhibits the growth of colon cancer, regulates inflammatory response, reduces dosage, significantly improves biochemical indicators caused by colon inflammation, enhances anti-colon cancer activity, has high safety performance, significantly reduces the expression of pro-inflammatory factors, and improves pathological state.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955751A_ABST
    Figure CN118955751A_ABST
Patent Text Reader

Abstract

The invention discloses a dandelion polysaccharide composition with the effect of assisting in inhibiting colon cancer. The dandelion polysaccharide composition comprises modified polysaccharide components DRP1 and DRP2, a preparation method of the modified polysaccharide components DRP1 and DRP2 comprises the following steps: preparing crude dandelion polysaccharide; separation of effective components: preparing and adjusting an ion exchange material; dissolving the dandelion root crude polysaccharide with distilled water, loading a sample, and eluting; performing detection; collecting, concentrating, dialyzing with a dialysis bag, and freeze-drying to obtain two separated effective components; purification of the effective components: the two separated effective components are respectively taken and purified by polysaccharide gel, and the purified effective components are obtained; and modification of the effective components: modifying the obtained purified effective components with sodium selenite. The dandelion polysaccharide composition disclosed by the invention has the effects of regulating and controlling inflammatory response and preventing colon cancer; in addition, the dandelion polysaccharide composition provided by the invention can greatly reduce the dosage on the premise of having a relatively good effect of inhibiting colon cancer.
Need to check novelty before this filing date? Find Prior Art